日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nivolumab in combination with ipilimumab versus capecitabine as post-operative treatment for triple negative breast cancer patients with residual disease after neoadjuvant chemotherapy: a multicentre, randomized, open-label phase II trial - BREASTIMMUNE-03

纳武利尤单抗联合伊匹木单抗对比卡培他滨作为新辅助化疗后残留病灶的三阴性乳腺癌患者术后治疗:一项多中心、随机、开放标签的II期试验 - BREASTIMMUNE-03

Trédan, Olivier; Loirat, Delphine; Chabaud, Sylvie; Toussaint, Philippe; Petit, Thierry; Viret, Frédéric; Levy, Christelle; Robert, Aurélien; Grenier, Julien; Mansi, Laura; Spano, Jean-Philippe; Patsouris, Anne; Derbel, Olfa; Jouannaud, Christelle; Ferrero, Jean Marc; Frenel, Jean Sébastien; Molin, Yann; Doublet, Louis; Heudel, Pierre-Etienne; Pierga, Jean-Yves; Garin, Gwenaële; Pérol, David; Bachelot, Thomas

Prospective pilot study with [(89)Zr]Zr-girentuximab PET/CT: CA-IX imaging in metastatic triple negative breast cancer (OPALESCENCE)

前瞻性试点研究:[(89)Zr]Zr-girentuximab PET/CT:CA-IX 成像在转移性三阴性乳腺癌中的应用 (OPALESCENCE)

Rousseau, Caroline; Heyman, M F; Ferrer, L; Rauscher, A; Morel, A; Rusu, D; Frenel, J S; Taupin, M; Vilcot, L; Allam, N; Robert, M; Campone, M; Campion, L; Kraeber-Bodéré, F

Treatment patterns and clinical outcomes in chemotherapy-treated patients with HR+/HER2- metastatic breast cancer using real-world data in France and Germany

利用法国和德国的真实世界数据,分析接受化疗的HR+/HER2-转移性乳腺癌患者的治疗模式和临床结果

Campone, Mario; Frenel, Jean-Sebastien; Kiver, Verena I I; Woeckel, Achim; Kerscher, Alexander; Krebs, Markus; Leal, Cátia; Saglimbene, Valeria M; Ann, Quratul; Sadetsky, Natalia; Sjekloca, Nikoleta; Libert, Olivier; Kaushik, Ankita; Bocquet, Francois

Development and Assessment of a Pipeline for Extracting Structured Data From Free-Text Medical Reports Using a Large Language Model

利用大型语言模型开发和评估从自由文本医疗报告中提取结构化数据的流程

Joseph, Enzo; Vallee, Paul; Perennec, Tanguy; Wagneur, Nicolas; Frenel, Jean-Sébastien; Campone, Mario; Bocquet, François; Le Borgne, Florent

Patritumab deruxtecan in HR(+)HER2(-) advanced breast cancer: a phase 2 trial

Patritumab deruxtecan治疗HR(+)HER2(-)晚期乳腺癌:一项II期试验

Pistilli, Barbara; Mosele, Fernanda; Corcos, Noemie; Pierotti, Livia; Pradat, Yoann; Le Bescond, Loic; Lacroix-Triki, Magali; Nachabeh, Ghada; Alfaro, Alexia; Catelain, Cyril; Job, Bastien; Mami-Chouaib, Fathia; Badel, Severine; Farace, Françoise; Oulhen, Marianne; Kannouche, Patricia; Tran, Diep T N; Droin, Nathalie; Vicier, Cecile; Frenel, Jean Sebastien; D'Hondt, Veronique; Dalenc, Florence; Bachelot, Thomas; Ducoulombier, Agnes; Benderra, Marc Antoine; Loirat, Delphine; Mayeur, Didier; Deluche, Elise; Deneuve, Jacqueline; Cheikh-Hussin, Rasha; Guyader, Pierre; Signolle, Nicolas; Godefroy, Karine; Talbot, Hugues; Vakalopoulou, Maria; Christodoulidis, Stergios; Bernard, Elsa; Koudou, Yves; Sporchia, Andrea; Suto, Fumitaka; Li, Lie; Sternberg, David W; Michiels, Stefan; André, Fabrice; Sellami, Dalila; Montagnac, Guillaume

Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial

铂类化疗后奥拉帕尼维持治疗晚期/转移性子宫内膜癌:GINECO随机IIb期UTOLA试验

Joly, Florence; Leary, Alexandra; Ray-Coquard, Isabelle; Asselain, Bernard; Rodrigues, Manuel; Gladieff, Laurence; Meynard, Guillaume; Abadie-Lacourtoisie, Sophie; Lebreton, Coriolan; Bengrine Lefevre, Leïla; Fournel, Pierre; Largillier, Rémy; Selle, Frédéric; Frenel, Jean-Sébastian; Fernandez Diez, Yolanda; Foa, Cyril; Follana, Philippe; Meunier, Jérôme; Fabbro, Michel; Hardy Bessard, Anne-Claire; Cojean-Zelek, Isabelle; Kaczmarek, Emilie; Bonnet, Elise; Arnaud, Antoine; Roche, Sophie; Leroy, Karen; Just, Pierre-Alexandre; Leman, Raphaël; Jeanne, Corinne; Callens, Céline; You, Benoit; Alexandre, Jérôme

Durvalumab and tremelimumab in combination with metronomic oral vinorelbine for recurrent advanced cervical cancer: an open-label phase I/II study

Durvalumab 和 tremelimumab 联合节拍式口服长春瑞滨治疗复发性晚期宫颈癌:一项开放标签 I/II 期研究

Frenel, Jean-Sébastien; Mathiot, Laurent; Cropet, Claire; Borcoman, Edith; Hervieu, Alice; Coquan, Elodie; De La Motte Rouge, Thibault; Saada-Bouzid, Esma; Sabatier, Renaud; Lavaud, Pernelle; Jimenez, Marta; Legrand, François; Le Saux, Olivia; Charafe, Emmanuelle; Gonçalves, Anthony

Real-world treatment patterns and effectiveness after disease progression on CDK4/6 inhibitors for HR-positive/HER2-negative metastatic breast cancer in the ESME-MBC cohort

ESME-MBC队列中HR阳性/HER2阴性转移性乳腺癌患者在接受CDK4/6抑制剂治疗后疾病进展的真实世界治疗模式和疗效

Varnier, R; Pérol, D; Jacot, W; Mailliez, A; Diéras, V; Dalenc, F; Gonçalves, A; Levy, C; Arnedos, M; Frenel, J-S; Bailleux, C; Massard, V; Brain, E; Sauterey, B; Savoye, A-M; Bosquet, L; Thery, J-C; Petit, T; Bachelot, T; Grinda, T; Ray-Coquard, I

PROMENADE: pembrolizumab for early ER-low/HER2-negative breast cancer, real-world French cohort

PROMENADE:帕博利珠单抗治疗早期ER低表达/HER2阴性乳腺癌,法国真实世界队列研究

Cherifi, F; Cabel, L; Bousrih, C; Volant, E; Dalenc, F; Mery, B; Auvray Kuentz, M; Mailliez, A; Ladoire, S; de Nonneville, A; Alexandre, M; Benistant, L; Leheurteur, M; Bailleux, C; Debled, M; Frenel, J-S; Loirat, D; Bastien, E; Aussedat, Q; Bidard, F C; Aho, S; Glenet, A; Mourato-Ribeiro, J; Johnson, A; Christy, F; Emile, G

Tremelimumab plus durvalumab combined to metronomic oral vinorelbine: Results from the breast cancer cohort of the phase II MOVIE study

曲美利单抗联合度伐利尤单抗,并配合节拍式口服长春瑞滨:来自 II 期 MOVIE 研究乳腺癌队列的结果

De La Motte Rouge, T; Frenel, J-S; Cropet, C; Borcoman, E; Hervieu, A; Emile, G; Augereau, P; Charafe, E; Legrand, F; Dassé, E; Gonçalves, A